Gregory Gene Freitag - Jun 28, 2022 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Director
Signature
/s/ Spencer Brown, as Attorney-in-Fact
Stock symbol
PDSB
Transactions as of
Jun 28, 2022
Transactions value $
$0
Form type
4
Date filed
6/29/2022, 04:15 PM
Previous filing
Jun 3, 2022
Next filing
Jul 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Stock Option (Right to Buy) Award $0 +9K $0.00 9K Jun 28, 2022 Common Stock 9K $3.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

Remarks:

Exhibit 24 - Power of Attorney